[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International Plc LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 126.50 123.00 130.00 - 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.5 -0.6 -4.7 - 20

Aortech Share Discussion Threads

Showing 8301 to 8321 of 8900 messages
Chat Pages: Latest  344  343  342  341  340  339  338  337  336  335  334  333  Older
DateSubjectAuthorDiscuss
06/1/2020
08:52
Brilliant.
the stigologist
06/1/2020
08:49
As usual, with companies of this nature, a bit of patience is required (!) but all seems to be moving solidly in the right direction.
semper vigilans
06/1/2020
08:42
I think Bill Brown’s Closing statement sums that message up succinctly. This is an important step being made to commit to the tooling so the level of confidence must be high. It is pretty much saying that whatever Foldax are testing with, Aortech can improve on those designs significantly as well as produce valves at a rate that ultimately will appeal to the majors: “The specialist equipment has also been designed to allow valve production to be industrialised going forward.” Scottish Enterprise have committed grants towards this so they must also have been persuaded of the merits of such an investment on behalf of the taxpayer. I suspect this RNS is also aimed at a wider audience than just the shareholders, as was mentioned once before in discussions on this thread.
bones
06/1/2020
07:20
06 January 2020 AorTech International PLC ("AorTech", the "Company" or the "Group") Heart Valve Development Update AorTech International plc (AIM: AOR.L), the licensor of the world's leading long-term implantable biostable polymer (Elast-Eon(TM) ) and developer of medical devices utilising the key properties of Elast-Eon(TM) , is pleased to update on the progress of the design for manufacture process for its polymeric heart valve. In its interim results announced on 29 November 2019, the Company stated that it was continuing to make good progress on both valve design and design for manufacture and that feedback from the process was currently driving further improvements. AorTech has generated a substantial amount of heart valve related intellectual property, including the relationship between defects in polymeric leaflets as a result of manufacturing limitations and valve durability. The design for manufacture project has been driven by a desire to eliminate both the design limitations and potential for defects of dip casting. The Company now believes that these limitations can be overcome by an alternative novel manufacturing process. Dip casting of valves can be successful, but is very difficult to both validate and achieve product consistency, thus placing a significant reliance on the quality control inspection procedures being able to identify any deficiencies in the heart valve leaflets. Much of the novel method of manufacture identified may lead to the creation of valuable new intellectual property for the Company. As a result, the Company is unable to disclose any further details regarding the method of manufacture, but is very pleased to announce that it has now committed to the design and manufacture of the bespoke equipment upon which proof of concept prototype valves will be produced. The specialist equipment has also been designed to allow valve production to be industrialised going forward. The objective of the project is to confirm the capabilities of the novel manufacturing technology that the Company is seeking to implement, which will then be followed by process optimisation, design freeze and a full set of ISO compliant testing programmes. This is a significant commitment from AorTech as part of its ongoing Research and Development plans. AorTech is delighted to report that the costs to be incurred are being partly financed through it having secured grant aid from Scottish Enterprise. Bill Brown, Chairman of AorTech, said: "This investment demonstrates the growing confidence in both the design of, and the novel manufacturing process for, the polymeric heart valve and we wish to thank Scottish Enterprise for their help and assistance towards this project. Through the design phase, our team has significantly improved valve performance and we are now targeting step changes in consistency and quality."
someuwin
06/1/2020
07:11
Big delay?
deltrotter
03/1/2020
17:20
GR, do you know something? An announcement next week would not surprise though.
landy90
03/1/2020
15:58
I'm expecting this to turn up next week. I think we'll get a more regular string of announcements this year given the key milestones that will be achieved. Good luck all.
greedy rooster
31/12/2019
17:52
Nice one Stig. Plenty of budgets for Elast-Eon Enabled devices there.
bones
31/12/2019
14:52
Saw this posted on another thread. Nice to dream going into 2020 THE TOP 10 MEDICAL DEVICE MANUFACTURERS Sales revenues 1. Medtronic $30.56B 2. Johnson & Johnson $26.99B 3. GE Healthcare $19.78B 4. Abbott $18.93B 5. Philips $16.09B 6. BD $15.98B 7. Cardinal Health $15.58B 7. Siemens Healthineers $15.58B 9. Stryker $13.60B 10. Baxter $11.12B
the stigologist
31/12/2019
10:59
That is very true Landy90. I was personally busy adding another 15% of my current holding in the 40’s and 50’s in early October while it was in the bargain bucket thanks to Miton and their mismanaged funds bailing out in a redemptions panic. Plus the summer was grim generally for small UK shares during the Parliamentary deadlock over Brexit. I know that some much heavier hitters were also accumulating at that time, including Walker Crips, hence their disclosure above 20% in October. The market for small caps looks set for a decent run up in 2020 so that should bode well for AOR assuming the business continues to progress as stated in recent RNS’s. I note that the AIM All-Share Index has recovered strongly in December (from 900 to 950 but still well off the 2018 highs of 1100+). Hope you all have a good evening tonight and best wishes for the New Year!
bones
31/12/2019
10:44
Miton were driving the slide down, once they left the ride it has been less bumpy.
landy90
31/12/2019
10:36
Agreed someuwin. A 100% rise sounds serene but the 2019 chart shows we have ridden the Big Dipper at Blackpool and it felt like we did it without wearing restraints. Looking at this chart, let’s hope the car has further to climb before it runs down any more hills! free stock charts from uk.advfn.com
bones
31/12/2019
09:49
I think we started 2019 at 50p and it looks like we'll end it at around 100p, giving 100% gain for the year. Hoping for even more in 2020 putting the share price well over 200p by end of the year!
someuwin
29/12/2019
20:08
TMK, yes, I like WEY, ZYT, SCE and TRIN at current prices and those are in my Stocko list for 2020 along With AOR of course. I have posted on all these and others occasionally. I keep tabs on about 200 companies overall. AOR is currently my main conviction stock as you suggest. I don’t feel a great desire yet to invest heavily elsewhere but I am sure I will once AOR’s value has been recognised by the market or a predator! Happy New Year....!
bones
29/12/2019
11:41
Hi Bones, do you have any other stocks on your radar screen? Surely, you don't have all your eggs in one basket (AOR). TMK
tees maar khan
27/12/2019
17:08
Seeing as we're tipping for 2020 I would add that in addition to AOR (where I've more than doubled on purchase price) I like ANIC - cultivated meat and fish DKE - mega-interesting micro property play ITX - recovery? ALGW - should come right this year SSTY - European property play Good luck for 2020.
ivor hunch
25/12/2019
20:51
Seriously, is everybody doing the regular be polite and get along thing. Can you get back to war now. It makes for better reading lol. AOR has performed extremely well. Lots more to come in the new year. Merry Christmas one and all! TMK
tees maar khan
24/12/2019
20:13
My thanks also to bones for maintaining an excellent thread.
langland
24/12/2019
15:22
Yes. Can't last.
the stigologist
24/12/2019
14:45
Ditto to all happy shareholders!
semper vigilans
24/12/2019
14:10
Have a good Xmas all!
davisc5
Chat Pages: Latest  344  343  342  341  340  339  338  337  336  335  334  333  Older
ADVFN Advertorial
Your Recent History
LSE
AOR
Aortech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211025 00:24:02